140 results on '"Digumarti R"'
Search Results
2. Pattern of metastases and their impact on outcomes in stage IV non small cell lung cancer – an institutional experience from South India: 201P
3. 276 Review of endometrial cancer management at an upcoming gynaecological oncology unit in India
4. 67 Problem solving using the A3 methodology for colposcopy
5. Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors
6. Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
7. Knowledge, attitude and practice of cervical cancer screening and vaccination among female relatives of cancer patients
8. Bortezomib in newly diagnosed patients with multiple myeloma: A retrospective analysis from a tertiary care center in India
9. Efficacy of rasburicase (recombinant urate oxidase) in the prevention and treatment of malignancy-associated hyperuricemia: An Indian experience
10. Standard operating procedure for audio visual recording of informed consent: An initiative to facilitate regulatory compliance
11. Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?
12. Chemotherapy for advanced lung cancer: A 5-year experience
13. 394O - Knowledge, attitude and practice of cervical cancer screening and vaccination among female relatives of cancer patients
14. 340P Cytogenetic and molecular response rates in AYA CML CP patients on imatinib based on the baseline BMI
15. 201P: Pattern of metastases and their impact on outcomes in stage IV non small cell lung cancer – an institutional experience from South India
16. Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
17. Bortezomib in newly diagnosed patients with multiple myeloma: A retrospective analysis from a tertiary care center in India
18. Bortezomib in newly diagnosed patients with multiple myeloma: A retrospective analysis from a tertiary care center in India.
19. A Randomized Phase 2 Study of Erlotinib Plus Pemetrexed vs Erlotinib or Pemetrexed Alone as Second-Line Treatment for Never-Smoker Patients with Non-Squamous Advanced Non-Small Cell Lung Cancer (NSCLC)
20. Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blastic crisis: A retrospective analysis.
21. Abstract P6-11-02: Final Analysis of NO16853, a Randomized Phase II Non-Inferiority Study of Two Different Doses of Capecitabine in Combination with Docetaxel for Locally Advanced/Metastatic Breast Cancer (LA/MBC)
22. Phase II study of bavituximab plus paclitaxel and carboplatin in untreated locally advanced or metastatic non-small cell lung cancer: Interim results.
23. Phase II study of bavituximab plus paclitaxel and carboplatin in locally advanced or metastatic breast cancer: Interim results.
24. Randomized phase III trial of pixantrone compared with other chemotherapeutic agents for third-line single-agent treatment of relapsed aggressive non-Hodgkin's lymphoma
25. A phase I study of pazopanib in combination with FOLFOX 6 or capeOx in subjects with colorectal cancer
26. Effect of oral talactoferrin (TLF) on levels of cytokines involved in the Th1-mediated immune response in clinical studies
27. A phase Ib safety and pharmacokinetic study of bavituximab plus chemotherapy in patients with refractory advanced solid tumor malignancies
28. Daunorubicin versus mitoxantrone for induction therapy of patients of de novo acute myeloid leukemia
29. Analysis of 210 febrile neutropenic episodes during induction therapy of acute myeloid leukemia (AML): An institutional experience from a developing country
30. Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
31. 1BA Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
32. A retrospective analysis of epidemiology and treatment patterns for gastric cancer at a tertiary health care center in India
33. Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer That Progressed After Chemotherapy.
34. A randomized, double-blind, placebo-controlled, phase II study of oral talactoferrin in combination with carboplatin and paclitaxel in previously untreated locally advanced or metastatic non-small cell lung cancer.
35. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non--small-cell lung cancer.
36. Safety, tolerability, and pharmacokinetics of a capsule formulation of DRF-1042, a novel camptothecin analog, in refractory cancer patients in a bridging phase I study.
37. Safety, tolerability, pharmacokinetics, and pharmacodynamics of an orally active novel comptothecin analog, DRF-1042, in refractory cancer patients in a phase I dose escalation study.
38. Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
39. Primary renal lymphoma presenting with paraneoplastic limbic encephalitis.
40. Modulatory effect of plasma folate and polymorphisms in one-carbon metabolism on catecholamine methyltransferase (COMT) H108L associated oxidative DNA damage and breast cancer risk
41. NRAS mutations in de novo acute leukemia: Prevalence and clinical significance
42. Reversible paraneoplastic encephalomyelitis as the presenting feature of ovarian teratoma: A clinicopathological correlate
43. Acute erythroid leukemia (AML-M6) - Is it rare?
44. Parasagittal hemangiopericytoma with late presentation of liver metastases: Case report and review of literature
45. Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial.
46. Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial
47. Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer.
48. Cervical Cancer in Low- and Middle-Income Countries: A Multidimensional Approach to Closing the Gaps.
49. Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature.
50. Organising Home-based Palliative Care Services: A Quality Improvement project at the Homi Bhabha Cancer Hospital and Research Centre, Vishakhapatnam.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.